Edward A. Miller

Array ( [id] => 5367087 [patent_doc_number] => 20090304646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Multipotent/Pluripotent Cells and Methods' [patent_app_type] => utility [patent_app_number] => 12/465633 [patent_app_country] => US [patent_app_date] => 2009-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 115777 [patent_no_of_claims] => 227 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20090304646.pdf [firstpage_image] =>[orig_patent_app_number] => 12465633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6126711 [patent_doc_number] => 20110086424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'METHODS FOR PRODUCING ENUCLEATED ERYTHROID CELLS DERIVED FROM PLURIPOTENT STEM CELLS' [patent_app_type] => utility [patent_app_number] => 12/991111 [patent_app_country] => US [patent_app_date] => 2009-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 50274 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086424.pdf [firstpage_image] =>[orig_patent_app_number] => 12991111 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5496486 [patent_doc_number] => 20090264514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'SPHINGOMYELIN SYNTHASE 2 (SMS2) DEFICIENCY ATTENUATES NFkB ACTIVATION, A POTENTIAL ANTI-ATHEROGENIC PROPERTY' [patent_app_type] => utility [patent_app_number] => 12/426324 [patent_app_country] => US [patent_app_date] => 2009-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8835 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20090264514.pdf [firstpage_image] =>[orig_patent_app_number] => 12426324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6619848 [patent_doc_number] => 20100293623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'Rabbit nuclear cloning method and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/386331 [patent_app_country] => US [patent_app_date] => 2009-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10274 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 36 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20100293623.pdf [firstpage_image] =>[orig_patent_app_number] => 12386331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8759875 [patent_doc_number] => 08420394 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-16 [patent_title] => 'Culturing ectodermal cells under reduced oxygen tension' [patent_app_type] => utility [patent_app_number] => 12/410406 [patent_app_country] => US [patent_app_date] => 2009-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8226 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12410406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6024840 [patent_doc_number] => 20110053166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'STEM CELL EXPRESSION CASSETTES' [patent_app_type] => utility [patent_app_number] => 12/920059 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 18723 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20110053166.pdf [firstpage_image] =>[orig_patent_app_number] => 12920059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5992511 [patent_doc_number] => 20110014164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'EFFICIENT INDUCTION OF PLURIPOTENT STEM CELLS USING SMALL MOLECULE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/867615 [patent_app_country] => US [patent_app_date] => 2009-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 19589 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20110014164.pdf [firstpage_image] =>[orig_patent_app_number] => 12867615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6204336 [patent_doc_number] => 20110067122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'Expression of Xenogenous (Human) Immunoglobulins in cloned, transgenic ungulates' [patent_app_type] => utility [patent_app_number] => 12/378061 [patent_app_country] => US [patent_app_date] => 2009-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 31482 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0067/20110067122.pdf [firstpage_image] =>[orig_patent_app_number] => 12378061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4495355 [patent_doc_number] => 07947501 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-24 [patent_title] => 'Gene recombination exchange system for stable gene modification in human ES cells' [patent_app_type] => utility [patent_app_number] => 12/322809 [patent_app_country] => US [patent_app_date] => 2009-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 50 [patent_no_of_words] => 10250 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/947/07947501.pdf [firstpage_image] =>[orig_patent_app_number] => 12322809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8375156 [patent_doc_number] => 08257947 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-04 [patent_title] => 'Extracellular matrix compositions produced under hypoxic culture conditions' [patent_app_type] => utility [patent_app_number] => 12/363488 [patent_app_country] => US [patent_app_date] => 2009-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 18782 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12363488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6460652 [patent_doc_number] => 20100190257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'Self-Assembly of a Cell-Microparticle Hybrid' [patent_app_type] => utility [patent_app_number] => 12/359336 [patent_app_country] => US [patent_app_date] => 2009-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4638 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20100190257.pdf [firstpage_image] =>[orig_patent_app_number] => 12359336 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5514185 [patent_doc_number] => 20090214491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Method Of Using Mitotically Inactivated Stem Cells For Damaged Tissue Repair' [patent_app_type] => utility [patent_app_number] => 12/354522 [patent_app_country] => US [patent_app_date] => 2009-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9020 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20090214491.pdf [firstpage_image] =>[orig_patent_app_number] => 12354522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9350215 [patent_doc_number] => 08669106 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-11 [patent_title] => 'Erythrocytes differentiated in vitro from nanofiber expanded CD133+ cells' [patent_app_type] => utility [patent_app_number] => 12/351630 [patent_app_country] => US [patent_app_date] => 2009-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 45 [patent_no_of_words] => 21597 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12351630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6071241 [patent_doc_number] => 20110046092 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'SMALL MOLECULES FOR NEURONAL DIFFERENTIATION OF EMBRYONIC STEM CELLS' [patent_app_type] => utility [patent_app_number] => 12/747116 [patent_app_country] => US [patent_app_date] => 2008-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 34011 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20110046092.pdf [firstpage_image] =>[orig_patent_app_number] => 12747116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6371848 [patent_doc_number] => 20100075421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'Efficient method for nuclear reprogramming' [patent_app_type] => utility [patent_app_number] => 12/292717 [patent_app_country] => US [patent_app_date] => 2008-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12908 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20100075421.pdf [firstpage_image] =>[orig_patent_app_number] => 12292717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6401085 [patent_doc_number] => 20100305039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'Production of collagen in the milk of transgenic mammals' [patent_app_type] => utility [patent_app_number] => 12/268412 [patent_app_country] => US [patent_app_date] => 2008-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 13343 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20100305039.pdf [firstpage_image] =>[orig_patent_app_number] => 12268412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5434937 [patent_doc_number] => 20090169523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'HSC SELF-RENEWAL' [patent_app_type] => utility [patent_app_number] => 12/268320 [patent_app_country] => US [patent_app_date] => 2008-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13869 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20090169523.pdf [firstpage_image] =>[orig_patent_app_number] => 12268320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4534232 [patent_doc_number] => 07888321 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-15 [patent_title] => 'Production of high levels of transgenic factor IX without gene rescue, and its therapeutic uses' [patent_app_type] => utility [patent_app_number] => 12/255325 [patent_app_country] => US [patent_app_date] => 2008-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14873 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/888/07888321.pdf [firstpage_image] =>[orig_patent_app_number] => 12255325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6540453 [patent_doc_number] => 20100287638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'NEURAL TUMOR STEM CELLS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/681036 [patent_app_country] => US [patent_app_date] => 2008-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 14905 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20100287638.pdf [firstpage_image] =>[orig_patent_app_number] => 12681036 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5521484 [patent_doc_number] => 20090029465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'Culturing Human Embryonic Stem Cells' [patent_app_type] => utility [patent_app_number] => 12/242085 [patent_app_country] => US [patent_app_date] => 2008-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4474 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20090029465.pdf [firstpage_image] =>[orig_patent_app_number] => 12242085 [rel_patent_id] =>[rel_patent_doc_number] =>)